KHA-CARI guideline: Early chronic kidney disease: Detection, prevention and management

Nephrology

Volumn 18, Issue 5, 2013, Pages 340-350

  Johnson, David W ^a   Atai, Emelia ^c   Chan, Maria ^d   Phoon, Richard K S ^c   Scott, Clodagh ^b   Toussaint, Nigel D ^g   Turner, Graeme L ^f   Usherwood, Tim ^e   Wiggins, Kathryn J ^g  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Australian Practice Nurses Association   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f Lismore Base Hospital ^*  (Australia)

^g ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN A1C; VITAMIN D;

ANEMIA; BLOOD CELL COUNT; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIET THERAPY; DIETARY FIBER; EARLY DIAGNOSIS; EXERCISE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; MEDITERRANEAN DIET; PATIENT EDUCATION; PHYSICAL ACTIVITY; POTASSIUM RESTRICTION; PRACTICE GUIDELINE; PREGNANCY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN DIET; PUBLIC HEALTH PROBLEM; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SMOKING CESSATION; SODIUM RESTRICTION; URINALYSIS; URINE CULTURE; VITAMIN D DEFICIENCY; WEIGHT CONTROL;

EARLY DIAGNOSIS; FEMALE; HUMANS; LIFE STYLE; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; REFERRAL AND CONSULTATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84876480297     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12052     Document Type: Review

References (44)

1. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J. Am. Soc. Nephrol. 2003; 14 (7 Suppl 2): S131-138.
2. John R, Webb M, Young A, Stevens P,. Unreferred chronic kidney disease: A longitudinal study. Am. J. Kidney Dis. 2004; 43: 825-835.
3. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr. Med. Res. Opin. 2004; 20 (9): 1501-1510.
4. McDonald SM, Excell L, Livingston B,. ANZDATA Registry Report 2008. Adelaide: Australian and New Zealand Dialysis and Transplant Registry, 2008.
5. Foley RN, Parfrey PS, Sarnak MJ,. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998; 32 (5 Suppl 3): S112-119.
6. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH,. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 2004; 164: 659-663.
7. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004; 15 (5): 1307-1315.
8. Li SQ, Cunningham J, Cass A,. Renal-related deaths in Australia 1997-1999. Intern. Med. J. 2004; 34: 259-265.
9. Johnson DW,. Evidence-based guide to slowing the progression of early renal insufficiency. Intern. Med. J. 2004; 34 (1-2): 50-57.
10. Churchill DN,. An evidence-based approach to earlier initiation of dialysis. Am. J. Kidney Dis. 1997; 30 (6): 899-906.
11. Binik YM, Devins GM, Barre PE, et al. Live and learn: Patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J. Nerv. Ment. Dis. 1993; 181: 371-376.
12. Curtis BM, Ravani P, Malberti F, et al. The short- and long-term impact of muti-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol. Dial. Transplant. 2005; 20: 147-154.
13. Ratcliffe PJ, Phillips RE, Oliver DO,. Late referral for maintenance dialysis. Br. Med. J. (Clin. Res. Ed.) 1984; 288 (6415): 441-443.
14. Sesso R, Belasco AG,. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol. Dial. Transplant. 1996; 11 (12): 2417-2420.
15. Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H,. Outcomes in patients with chronic kidney disease referred late to nephrologists: A meta-analysis. Am. J. Med. 2007; 120: 1063-1070.
16. Jungers P, Zingraff J, Page B, Albouze G, Hannedouche T, Man NK,. Detrimental effects of late referral in patients with chronic renal failure: A case-control study. Kidney Int. Suppl. 1993; 41: S170-173.
17. Levinsky NG,. Specialist evaluation in chronic kidney disease: Too little, too late. Ann. Intern. Med. 2002; 137: 542-543.
18. Jungers P, Zingraff J, Albouze G, et al. Late referral to maintenance dialysis: Detrimental consequences. Nephrol. Dial. Transplant. 1993; 8 (10): 1089-1093.
19. Jungers P, Joly D, Nguyen-Khoa T, Mothu N, Bassilios N, Grunfeld J-P,. [Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement]. Presse Med. 2006; 35 (1 Pt 1): 17-22. Retard persistant au suivi nephrologique de l'insuffisance renale chronique.
20. Smart NA, Titus TT,. Outcomes of early versus late nephrology referral in chronic kidney disease: A systematic review. Am. J. Med. 2011; 124: 1073-1080.e2.
21. Cass A, Cunningham J, Snelling P, Ayanian JZ,. Late referral to a nephrologist reduces access to renal transplantation. Am. J. Kidney Dis. 2003; 42: 1043-1049.
22. The Royal Australian College of General Practitioners 'Red Book' Taskforce. Guidelines for Preventive Activities in General Practice, 7th edn. South Melbourne, Vic.: The Royal Australian College of General Practitioners, 2009.
23. NACCHO/RACGP. National Guide to A Preventive Health Assessment in Aboriginal and Torres Strait Islander People, 2nd edn. South Melbourne, Vic.: The RACGP, 2012.
24. Johnson DW, Mathew T, Ludlow M, et al. Chronic Kidney Disease (CKD) Management in General Practice. Melbourne, Vic.: Kidney Health Australia, 2007.
25. White SL, Polkinghorne KR, Cass A, Shaw J, Atkins RC, Chadban SJ,. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med. J. Aust. 2008; 188: 204-208.
26. Ormandy P, Hulme C, Caress A-L, Macdonald J, O'Donoghue D, Crane D,. Executive Summary-Identifying Chronic Kidney Disease Patients' Priorities and Preferences for Information Topics. Manchester: Institute for Health and Social Care Research Report, University of Salford, 2007.
27. Nunes JAW, Wallston KA, Eden SK, Shintani AK, Ikizler TA, Cavanaugh KL,. Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int. 2011; 80 (12): 1344-1351.
28. Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial. Med. Care 1999; 37: 5-14.
29. 1c Consensus Committee. 2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1c Measurement. Pediatr. Diabetes 2010; 11 (4): 209-211.
30. Jones GRD, Barker G, Goodall I, Schneider HG, Shephard MDS, Twigg SM,. Change of HbA1c reporting to the new SI units. Med. J. Aust. 2011; 195: 45-46.
31. Mandayam S, Mitch WE,. Dietary protein restriction benefits patients with chronic kidney disease. Nephrology 2006; 11: 53-57.
32. Valtin H,. 'Drink at least eight glasses of water a day.' Really? Is there scientific evidence for '8 x 8'? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002; 283: R993-1004.
33. Reichard P, Nilsson BY, Rosenqvist U,. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Engl. J. Med. 1993; 329: 304-309.
34. UKPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352 (9131): 854-865.
35. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352 (9131): 837-853.
36. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373 (9678): 1849-1860.
37. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH,. An update on aspirin in the primary prevention of cardiovascular disease. Arch. Intern. Med. 2003; 163 (17): 2006-2010.
38. Jardine MJ, Ninomiya T, Perkovic V, et al. Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial. J. Am. Coll. Cardiol. 2010; 56 (12): 956-965.
39. National Vascular Disease Prevention Alliance. Guidelines for the Management of Absolute Cardiovascular Disease Risk. Melbourne, Vic: National Stroke Foundation, 2012.
40. Avram Z, Krishnan E,. Hyperuricaemia-where nephrology meets rheumatology. Rheumatology 2008; 47 (7): 960-964.
41. Badve SV, Brown F, Hawley CM, et al. Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nat. Rev. Nephrol. 2011; 7 (5): 295-300.
42. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F,. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp. Gerontol. 2008; 43: 347-352.
43. Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75: 88-95.
44. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS,. 25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am. J. Kidney Dis. 2007; 50: 69-77.